Epigenomics has appointed Jorge Garces as president and CSO, effective Dec. 1. He will join the firm's executive board and oversee operations, R&D, clinical affairs, regulatory and quality. Prior to joining Epigenomics, Garces was CEO and president of AltheaDx. Before that, he held the same positions at Enigma Diagnostics. He also has held management positions at Hologic and GenMark Diagnostics, as well as Third Wave Technologies.